Keynote Speaker: William G. Dixon, MD PhD – University of Manchester
### @@@ Kathryn Rough, ScD, ScM (she/her/hers) – IQVIA ### 1653783###Speaker###Associate Director of Epidemiology###IQVIA###Speaker: Kathryn Rough, ScD, ScM (she/her/hers) – IQVIA
### she/her/hers @@@ Paul Strijbos, PhD (he/him/his) – F. Hoffmann-La Roche ### 2412788###Speaker###Senior Principal Neurotech Innovation Leader###F. Hoffmann-La Roche###Speaker: Paul Strijbos, PhD (he/him/his) – F. Hoffmann-La Roche
### he/him/his @@@ Martin Seneviratne, MBBS MS (he/him/his) – Phare Health ### 2412789###Speaker###Co-Founder###Phare Health###Speaker: Martin Seneviratne, MBBS MS (he/him/his) – Phare Health
### he/him/his @@@ Nancy A. Dreyer, PhD, MPH, FISPE, Fellow DIA (she/her/hers) – Dreyer Strategies LLC ### 1046833###Chairperson###Chief Scientific Officer, IQVIA Real-World Solutions, Retired###Dreyer Strategies LLC###Chairperson: Nancy A. Dreyer, PhD, MPH, FISPE, Fellow DIA (she/her/hers) – Dreyer Strategies LLC
### she/her/hers @@@ Daniel A. Caños, PhD, MPH ### 2406272###Chairperson#########Chairperson: Daniel A. Caños, PhD, MPH
###Lead Speaker: Meredith Y. Smith, PhD, MPA, FISPE – Evidera. Inc., PPD, a part of Thermo Fisher Scientific
### @@@ Mehmet Burcu, PhD, MS (he/him/his) – Merck & Co., Inc., Rahway, NJ, United States ### 1088178###Speaker###Sr. Director###Merck & Co., Inc., Rahway, NJ, United States###Speaker: Mehmet Burcu, PhD, MS (he/him/his) – Merck & Co., Inc., Rahway, NJ, United States
### he/him/his @@@ Gita A. Toyserkani, PharmD, MBA – US Food and Drug Administration ### 1360117###Speaker###Associate Director for Research and Strategic Initiatives###US Food and Drug Administration###Speaker: Gita A. Toyserkani, PharmD, MBA – US Food and Drug Administration
### @@@ Elaine H. Morrato, DrPH FISPE – Loyola University of Chicago ### 1046822###Speaker###Professor and Dean###Loyola University of Chicago###Speaker: Elaine H. Morrato, DrPH FISPE – Loyola University of Chicago
###Presenting Author: Kueiyu Joshua Lin, MD, ScD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School
### @@@ Daniel E. Singer, MD – Massachusetts General Hospital, Boston, MA ### 1360618###Co-Author###Professor of Medicine, Harvard Medical School###Massachusetts General Hospital, Boston, MA###Co-Author: Daniel E. Singer, MD – Massachusetts General Hospital, Boston, MA
### @@@ Darae Ko – Hebrew Rehabilitation Center, Harvard Medical School ### 2325571###Co-Author######Hebrew Rehabilitation Center, Harvard Medical School###Co-Author: Darae Ko – Hebrew Rehabilitation Center, Harvard Medical School
### @@@ Yichi Zhang – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School ### 1658130###Co-Author######Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School###Co-Author: Yichi Zhang – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School
### @@@ Alexander Cervone – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School ### 1991377###Co-Author######Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School###Co-Author: Alexander Cervone – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School
### @@@ Dae Hyun Kim, MD, ScD – Hebrew SeniorLife Marcus Institute for Aging Research ### 1655334###Co-Author###Associate Professor of Medicine, Harvard Medical School###Hebrew SeniorLife Marcus Institute for Aging Research###Co-Author: Dae Hyun Kim, MD, ScD – Hebrew SeniorLife Marcus Institute for Aging Research
###